These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20004545)

  • 21. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.
    Visvanathan K; Chlebowski RT; Hurley P; Col NF; Ropka M; Collyar D; Morrow M; Runowicz C; Pritchard KI; Hagerty K; Arun B; Garber J; Vogel VG; Wade JL; Brown P; Cuzick J; Kramer BS; Lippman SM;
    J Clin Oncol; 2009 Jul; 27(19):3235-58. PubMed ID: 19470930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From adjuvant therapy to breast cancer prevention: BCPT and STAR.
    Dunn BK; Ford LG
    Breast J; 2001; 7(3):144-57. PubMed ID: 11469927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.
    Bender CM; Sereika SM; Brufsky AM; Ryan CM; Vogel VG; Rastogi P; Cohen SM; Casillo FE; Berga SL
    Menopause; 2007; 14(6):995-8. PubMed ID: 17898668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
    Bevers TB
    J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
    Ganz PA; Land SR
    Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer.
    Banegas MP; McClure JB; Barlow WE; Ubel PA; Smith DM; Zikmund-Fisher BJ; Greene SM; Fagerlin A
    Patient Educ Couns; 2013 Jun; 91(3):364-71. PubMed ID: 23395006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.
    Martino S; Costantino J; McNabb M; Mershon J; Bryant K; Powles T; Secrest RJ
    Oncologist; 2004; 9(2):116-25. PubMed ID: 15047916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Fu R; Zakher B; Pappas M; McDonagh M
    JAMA; 2019 Sep; 322(9):868-886. PubMed ID: 31479143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facilitating decision-making in women undergoing genetic testing for hereditary breast cancer: BRECONDA randomized controlled trial results.
    Sherman KA; Kilby CJ; Shaw LK; Winch C; Kirk J; Tucker K; Elder E
    Breast; 2017 Dec; 36():79-85. PubMed ID: 29031121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women's views on chemoprevention of breast cancer: qualitative study.
    Heisey R; Pimlott N; Clemons M; Cummings S; Drummond N
    Can Fam Physician; 2006 May; 52(5):624-5. PubMed ID: 17327893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The selective estrogen receptor modulators in breast cancer prevention.
    Li F; Dou J; Wei L; Li S; Liu J
    Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR).
    Holmberg C; Waters EA; Whitehouse K; Daly M; McCaskill-Stevens W
    Med Decis Making; 2015 Nov; 35(8):1010-22. PubMed ID: 26183166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lack, need, and opportunities for decision-making and informational tools to educate primary-care physicians and women about breast cancer chemoprevention.
    Ravdin PM
    Cancer Prev Res (Phila); 2010 Jun; 3(6):686-8. PubMed ID: 20522798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
    Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
    J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM; Wolmark N
    Clin Breast Cancer; 2002 Jun; 3(2):153-9. PubMed ID: 12123540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Italian breast cancer prevention trial with tamoxifen: findings and new perspectives.
    Guerrieri-Gonzaga A; Galli A; Rotmensz N; Decensi A
    Ann N Y Acad Sci; 2001 Dec; 949():113-22. PubMed ID: 11795343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should We Offer Medication to Reduce Breast Cancer Risk?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Burns RB; Schonberg MA; Tung NM; Libman H
    Ann Intern Med; 2016 Aug; 165(3):194-204. PubMed ID: 27479221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer chemoprevention.
    Rosenbaum Smith SM; Osborne MP
    Am J Surg; 2000 Oct; 180(4):249-51. PubMed ID: 11113429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer chemoprevention: A service in need of menopause specialist support.
    Marsden J
    Post Reprod Health; 2017 Mar; 23(1):15-21. PubMed ID: 28081658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.